Scholar Rock Secures U.S. Patent for Potential SMA Therapy Targeting Myostatin
Biotech company Scholar Rock has Secured a key U.S. Patent for a Potential SMA Therapy that targets Myostatin
The U.S. Patent and Trademark Office has issued a patent for antibodies ... Read more